Department of Orthopaedic Surgery, Indiana University School of Medicine, IN, USA; Richard L. Roudebush VA Medical Center, IN, USA.
Department of Biology, Indiana University Purdue University Indianapolis, IN, USA.
Bone. 2021 May;146:115883. doi: 10.1016/j.bone.2021.115883. Epub 2021 Feb 11.
Angiogenesis is a vital process during the regeneration of bone tissue. The aim of this study was to investigate angiogenesis at the fracture site as well as at distal locations from obesity-induced type 2 diabetic mice that were treated with bone morphogenetic protein-2 (BMP-2, local administration at the time of surgery) to heal a femoral critical sized defect (CSD) or saline as a control. Mice were fed a high fat diet (HFD) to induce a type 2 diabetic-like phenotype while low fat diet (LFD) animals served as controls. Endothelial cells (ECs) were isolated from the lungs (LECs) and bone marrow (BMECs) 3 weeks post-surgery, and the fractured femurs were also examined. Our studies demonstrate that local administration of BMP-2 at the fracture site in a CSD model results in complete bone healing within 3 weeks for all HFD mice and 66.7% of LFD mice, whereas those treated with saline remain unhealed. At the fracture site, vessel parameters and adipocyte numbers were significantly increased in BMP-2 treated femurs, irrespective of diet. At distal sites, LEC and BMEC proliferation was not altered by diet or BMP-2 treatment. HFD increased the tube formation ability of both LECs and BMECs. Interestingly, BMP-2 treatment at the time of surgery reduced tube formation in LECs and humeri BMECs. However, migration of BMECs from HFD mice treated with BMP-2 was increased compared to BMECs from HFD mice treated with saline. BMP-2 treatment significantly increased the expression of CD31, FLT-1, and ANGPT2 in LECs and BMECs in LFD mice, but reduced the expression of these same genes in HFD mice. To date, this is the first study that depicts the systemic influence of fracture surgery and local BMP-2 treatment on the proliferation and angiogenic potential of ECs derived from the bone marrow and lungs.
血管生成是骨组织再生过程中的一个重要过程。本研究旨在探讨肥胖诱导的 2 型糖尿病小鼠骨折部位及远端部位的血管生成情况,这些小鼠接受骨形态发生蛋白-2(BMP-2,手术时局部给药)治疗以愈合股骨临界尺寸缺损(CSD),或接受生理盐水作为对照。将高脂肪饮食(HFD)喂养的小鼠诱导为 2 型糖尿病样表型,而低脂肪饮食(LFD)动物作为对照。手术后 3 周从肺部(LEC)和骨髓(BMEC)分离内皮细胞(EC),并检查骨折股骨。我们的研究表明,在 CSD 模型中,局部给予 BMP-2 可使所有 HFD 小鼠和 66.7%的 LFD 小鼠在 3 周内完全愈合骨折,而接受生理盐水治疗的小鼠仍未愈合。在骨折部位,无论饮食如何,BMP-2 处理的股骨中血管参数和脂肪细胞数量均显著增加。在远端部位,饮食或 BMP-2 处理并不改变 LEC 和 BMEC 的增殖。HFD 增加了 LEC 和 BMEC 的管形成能力。有趣的是,手术时给予 BMP-2 治疗可降低 LEC 和肱骨 BMEC 的管形成能力。然而,与接受生理盐水治疗的 HFD 小鼠的 BMEC 相比,接受 BMP-2 治疗的 HFD 小鼠的 BMEC 迁移增加。BMP-2 治疗显著增加了 LFD 小鼠中 LEC 和 BMEC 中 CD31、FLT-1 和 ANGPT2 的表达,但降低了 HFD 小鼠中这些基因的表达。到目前为止,这是第一项描述骨折手术和局部 BMP-2 治疗对骨髓和肺部来源的 EC 增殖和血管生成潜力的系统影响的研究。